glp 1 drugs and cholesterol GLP-1 Medications Infographic GLP-1 drugs can help you

During 2024 and 2025, the GLP-1 class was increasingly defined by expanded use cases and approvals, with existing drugs gaining indications including cardiovascular risk, sleep apnea and kidney disease

For the case of hip fracture, we found a crude HR of 0.68 [0.490.96] and a similar adjusted HR

These factors support GLP-1 use in diabetes and obesity treatment

[DOI] [PMC free article] [PubMed] [Google Scholar] 36.Aldawsari M, Almadani FA, Almuhammadi N, Algabsani S, Alamro Y, Aldhwayan M

If you are like many of our clients in the food and beverage or food service industries, you might wonder how your brand should respond to changing consumption patterns related to the widespread GLP-1 usage

Liraglutide , marketed under the brand name Saxenda, is one such treatment approved for chronic weight management in individuals with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher who have at least one weight-related condition